REG - MyHealthChecked PLC - Directorate Change

MyhealthcheckedAnnouncement

26/06/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230626:nRSZ8046Da&default-theme=true

RNS Number : 8046D  MyHealthChecked PLC  26 June 2023

 

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

 

Directorate Change

Appointment of Non-Executive Director

 

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company,
announces the proposed appointment of Amber Vodegel as a Non-Executive
Director of the Company with effect 3 July 2023.

 

Amber is the Founder and original Owner of Health and Parenting Ltd, a
HealthTech company that created the Company's flagship application Pregnancy+,
one of the largest pregnancy apps worldwide, growing the user base to over two
million daily active users. Amber managed Pregnancy+ as part of a suite of
health apps under Health & Parenting Ltd from 2012 until the company was
acquired by Philips in 2017. Following the acquisition she held the position
of Business Leader and Transformation Advisor within Philips BG MCC. Amber has
worked with MyHealthChecked in an advisory capacity for the past 5 months and
brings to MyHealthChecked a strong knowledge of digital strategy in the
healthcare space and a global network of contacts.  Amber also brings
experience in mobile app development, digital transformation, and platform
development for the Health- and FemTech space, with a focus on driving
consumer obsession and maximising user engagement. Previously, Amber worked as
a Strategy Director at a digital advertising agency with a focus on large
social media campaigns as well as helping various Apps reach the number one
position in their category.

 

Amber is the winner of the UK's 'First Women of Healthcare Award' and was
shortlisted for the 2016 NatWest 'everywoman Awards'.

 

Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, said: "It is
a pleasure to welcome Amber to the Board of MyHealthChecked. Amber brings with
her not only a wealth of experience in the health tech sector but also a
passion and commitment to quality, ethics and the use of innovative technology
to make the world a better place. Amber's experience in digital strategy
hugely complements our business strategy and she is a fantastic addition to
the MyHealthChecked team and our Board of Directors."

 

Commenting, Amber Vodegel, said: "I am thrilled to be part of the Board of
MyHealthChecked, as my passion lies in supporting businesses that disrupt
existing markets and create a positive impact in healthcare. Joining forces
with this passionate team is truly a privilege, especially considering their
impressive achievements through the successful launch of the innovative
at-home testing range. It is an incredibly exciting time to be joining the
business and I look forward to contributing to its growth."

 

The following additional information is provided in accordance with paragraph
(g) of Schedule Two to the AIM Rules for Companies:

 

Amber Ilja Vodegel (49) is currently or has been a director of the following
companies within the previous five years:

 

 Current directorships/partnerships  Past directorships/partnerships
 Consulens Limited                   Ambion Consulting Ltd

                                     Ambion Investment Ltd

 

Ms Vodegel holds no  ordinary shares in the Company.

 

Save as set out above, no further information is required to be disclosed
pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.

 

For further information contact:

 

 MyHealthChecked PLC                                                www.myhealthchecked.com (http://www.myhealthchecked.com)
 Penny McCormick, Chief Executive Officer                           via Walbrook PR

 SPARK Advisory Partners Limited (NOMAD)                            Tel: +44 (0)20 3368 3550
 Neil Baldwin / Jade Bayat

 Dowgate Capital Limited (Broker)                                   Tel: +44 (0)20 3903 7715
 David Poutney / Nicholas Chambers

 Walbrook PR Ltd (Media & IR)      Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
                                   (mailto:myhealthcheckedplc@walbrookpr.com)
 Paul McManus / Alice Woodings                                      Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

About MyHealthChecked PLC (https://investors.myhealthchecked.com/
(https://investors.myhealthchecked.com/) )

 

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK
healthcare company focused on a range of at-home healthcare and wellness
tests.

 

MyHealthChecked (http://www.myhealthchecked.com) is the umbrella brand of a
range of at-home rapid tests, as well as DNA, RNA and blood sample collection
kits which have been created to support customers on their journeys to
wellness. The tests are lateral-flow self-tests, whilst the sample collection
kits enable the collection of blood, urine, nasal or mouth swab samples that
are analysed in partner laboratories for a range of biomarkers. The tests will
also be made available online and will be viable for over-the-counter
purchase.

 

The MyHealthChecked portfolio has been identified as part of a change in
mindset as customers become more familiar with the concept of accessible
healthcare in the growing at home testing kit market with a focus on
accessibility at the right price, led by UK-based experts.

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK
VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH
LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED.  ON
PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS
INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAMZGZVNFRGFZM